Table 7.
Multivariate analysis of triple negative breast cancer survival
| Included parameters | Disease-free survival | Overall survival | ||||
|---|---|---|---|---|---|---|
| Hazard ratio | 95 % CI | p value | Hazard ratio | 95 % CI | p value | |
| Histologic grade | 0.560 | 0.204 | ||||
| I/II versus III | 0.725 | 0.246–2.136 | 0.537 | 0.206–1.402 | ||
| T stage | 0.027 | 0.016 | ||||
| T1 versus T2/T3 | 10.21 | 1.306–79.90 | 6.317 | 1.413–28.23 | ||
| Lymph node metastasis | 0.019 | 0.013 | ||||
| No versus Yes | 3.918 | 1.254–12.24 | 3.564 | 1.304–9.740 | ||
| Ki-67 LI | 0.327 | 0.711 | ||||
| ≤14 versus >14 | 0.581 | 0.197–1.719 | 1.209 | 0.443–3.298 | ||
| Stromal type | 0.988 | 0.699 | ||||
| Desmoplastic/sclerotic versus inflammatory | 0.990 | 0.266–19.15 | 1.287 | 0.359–4.613 | ||
| PD-L1 (28-8) (I) | 0.081 | 0.036 | ||||
| Negative versus positive | 4.019 | 0.843–19.15 | 5.112 | 1.110–23.54 | ||
Italics represents p < 0.05
I immune cell